TOP ARTICLES
Extracorporeal photopheresis as graft-versus-host disease prophylaxis: a randomized controlled trial: prophylactic extracorporeal photopheresis to prevent graft-versus-host disease. Ali, M.M., et al. (2023). Transplantation and Cellular Therapy. [Record in progress].
Randomized controlled trial comparing ferrous sulfate and iron sucrose in iron deficiency anemia in pregnancy. Chauhan, N., et al. (2023). Cureus.
Routine versus on-demand blood sampling in critically ill patients: a systematic review. Hjortso, C.J.S., et al. (2023). Critical Care Medicine. [Record in progress].
An individualized red blood cell transfusion strategy using pediatric perioperative-transfusion-trigger score reduced perioperative blood exposure for children: a randomized controlled clinical trial. Luo, Z., et al. (2023). Therapeutics and Clinical Risk Management.
Outcomes of transfusion with whole blood, component therapy, or both in adult civilian trauma patients: a systematic review and meta-analysis. Ngatuvai, M., et al. (2023). The Journal of Surgical Research.
Deferoxamine in intracerebral hemorrhage: systematic review and meta-analysis. Sun, T., et al. (2023). Clinical Neurology and Neurosurgery.
Ferric carboxymaltose infusion versus oral iron supplementation for preoperative iron deficiency anaemia in patients with colorectal cancer (FIT): a multicentre, open-label, randomised, controlled trial. Talboom, K., et al. (2023). The Lancet. Haematology.
Comparative efficacy and safety of different hemostatic medications during spinal surgery: a network meta-analysis. Tan, H., et al. (2023). Medicine.
Pegcetacoplan controls hemolysis in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria. Wong, R.S.M., et al. (2023). Blood Advances. [Record in progress].
ARTICLE OF THE MONTH Efficacy and safety of early administration of 4-factor prothrombin complex concentrate in patients with trauma at risk of massive transfusion: The PROCOAG randomized clinical trial. Bouzat, P., et al. (2023). JAMA. [Record in progress].PICO Summary available +++++ |
No comments:
Post a Comment